Order Article Reprints

Citi V, Barresi E, Piragine E, Spezzini J, Testai L, Da Settimo F, Martelli A, Taliani S, Calderone V. Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H₂S Donor Moiety, in Different Cancer Cell Lines. International Journal of Molecular Sciences. 2023; 24(22):16131. https://doi.org/10.3390/ijms242216131

Citi, Valentina, Elisabetta Barresi, Eugenia Piragine, Jacopo Spezzini, Lara Testai, Federico Da Settimo, Alma Martelli, Sabrina Taliani, and Vincenzo Calderone. 2023. "Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H₂S Donor Moiety, in Different Cancer Cell Lines" International Journal of Molecular Sciences 24, no. 22: 16131. https://doi.org/10.3390/ijms242216131

Citi, V., Barresi, E., Piragine, E., Spezzini, J., Testai, L., Da Settimo, F., Martelli, A., Taliani, S., & Calderone, V. (2023). Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H₂S Donor Moiety, in Different Cancer Cell Lines. International Journal of Molecular Sciences, 24(22), 16131. https://doi.org/10.3390/ijms242216131